Myocet Plus Endoxan for Older Patients With Breast Cancer

NCT01120171 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

64

Enrollment

OTHER

Sponsor class

Stopped Due to poor accrual

Conditions

Breast Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Liposomal-encapsulated doxorubicin

Sponsor

Hellenic Oncology Research Group